Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.20.2
Summary of Significant Accounting Policies (Details)
 3 Months Ended 9 Months Ended
Aug. 05, 2020
USD ($)
Aug. 15, 2019
$ / shares
Sep. 30, 2020
USD ($)
$ / shares
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Sep. 30, 2020
USD ($)
$ / shares
Sep. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
$ / shares
Dec. 31, 2018
USD ($)
Reverse stock split, Ratio   0.10                    
Common stock, par value | $ / shares   $ 0.001 $ 0.001           $ 0.001   $ 0.001  
Net loss     $ (4,894,739) $ (833,258) $ (930,501) $ (812,711) $ (1,251,682) $ (1,040,899) $ (6,658,498) $ (3,105,292)    
Net Cash Provided by (Used in) Operating Activities, Continuing Operations                 (2,303,639) (1,876,140)    
Working Capital     3,400,000           3,400,000      
Cash and cash equivalents     $ 3,769,225     $ 769,833     3,769,225 769,833 $ 3,057,682 $ 3,258,077
Proceeds from the exercise of warrants $ 2,500,000               $ 2,972,018 $ 0    
Revenue, Product and Service [Extensible List]     us-gaap:GrantMember     us-gaap:GrantMember     us-gaap:GrantMember us-gaap:GrantMember    
Grant revenue     $ 147,787     $ 0     $ 154,302 $ 0    
Cost, Product and Service [Extensible List]     us-gaap:GrantMember     us-gaap:GrantMember     us-gaap:GrantMember us-gaap:GrantMember    
Cost of product revenue     $ 147,787           $ 154,302      
Accounts Receivable                        
Revenue, Product and Service [Extensible List]                 us-gaap:GrantMember      
Unbilled receivables     $ 28,623           $ 28,623      
Pre Funded Warrants                        
Common stock, par value | $ / shares     $ 0.001           $ 0.001      
B TRAN Devices | Diversified Technologies Inc                        
Grant revenue                 $ 1,200,000      
Supplier contract term                 2 years